The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions
Open accessThe DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Abstract
Drug addiction causes constant serious health, social, and economic burden within the human society. The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco, and even symptomatic for stimulants and cannabinoids, thus, new more effective treatment strategies are researched. The antagonism of the growth hormone secretagogue receptor type A (GHS-R1A) has been recently proposed as a novel alcohol addiction treatment strategy, and it has been intensively studied in experimental models of other addictive drugs, such as nicotine, stimulants, opioids and cannabinoids. The role of ghrelin signaling in these drugs effects has also been investigated. The present review aims to provide a comprehensive overview of preclinical and clinical studies focused on ghrelin’s/GHS-R1A possible involvement in these nonalcohol addictive drugs reinforcing effects and addiction. Although the investigation is still in its early stage, majority of the existing reviewed experimental results from rodents with the addition of few human studies, that searched correlations between the genetic variations of the ghrelin signaling or the ghrelin blood content with the addictive drugs effects, have indicated the importance of the ghrelin’s/GHS-R1As involvement in the nonalcohol abused drugs pro-addictive effects. Further research is necessary to elucidate the exact involved mechanisms and to verify the future potential utilization and safety of the GHS-R1A antagonism use for these drug addiction therapies, particularly for reducing the risk of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical studies suggest that ghrelin/GHS-R1a has a significant role in the reinforcing effects of opioids, and in preclinical addiction studies, GHS-R1a antagonism decreased the opioid reward and the symptoms of craving for opioids (139).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · cited 3×
“The only orexigenic gut-brain peptide hormone, ghrelin, commonly called “hunger hormone”, has been extensively studied for more than 20 years since its discovery [33].”
BackgroundInfluentialThe neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · cited 1×
“Furthermore, behavioral sensitization (associated with accumbens dopaminergic sensitization), which is caused by repeated addictive drug administration, is considered within certain limits to be a manifestation of the incentive motivation of underlying drugseeking behavior [18,102,103].”
BackgroundDi Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · cited 1×
“Previously, it was suggested that not only the dopamine release in the NAC shell, but the concomitant dopamine release in the VTA and NAC shell might represent a common underlying characteristic induced by various reinforcing stimuli, including natural rewards such as food/water [179], drugs of abuse [12,180,181] and…”
BackgroundNeurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698 · cited 3×
“Drug addiction is a chronic relapsing brain disease triggered by repeated drug exposures in individuals who are vulnerable due to genetic predispositions and developmental or adverse social exposures [5,6].”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., Hamelin, M., Hreniuk, D. L., Palyha, O. C., Anderson, J., et al. (1996) · Science · doi:10.1126/science.273.5277.974 · Cited by 2,073 · cited 1×
“Acyl-ghrelin mediates its plentiful peripheral as well as central physiological functions through the GHS-R1A, which is encoded by the GHSR gene on chromosome 3 [56,57].”
BackgroundIs there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,346
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,241
Cited by
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 39
“Cont.”
Etxandi, M., Baenas, I., Mora‐Maltas, B., Granero, R., Fernández‐Aranda, F., Tovar, S. A., Solé‐Morata, N., Lucas, I., Casado, S., Gómez‐Peña, M., et al. (2022) · Nutrients · doi:10.3390/nu14235084 · Cited by 16
“Noticeably, ghrelin up-regulation has been described in SUDs, which positively correlates with craving, abstinence, and relapse [17–19].”
BackgroundInfluentialExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Tunagur, E. M. K., Yazıcı, A. B., Güzel, D., Tunagür, M. T., Ermiş, Ç., Suda, M. A., & Yazıcı, E. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109577 · Cited by 9
Orellana, E. R., Horvath, N., Farokhnia, M., Leggio, L., & Hajnal, A. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.019 · Cited by 9
Metadata
- Authors
- Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R.
- Affiliations
- Department of Pharmacology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic
- Charles University (CZ)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-11
- Volume
- 23
- Issue
- 2
- Pages
- 761
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8776007
- OpenAlex
- W4206420944
- Semantic Scholar
- aa8b6baae25d8dd94aa269e1d610480af54eb54f
- Cited by
- 12
- References
- 234
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Univerzita Karlova v Praze (260533/SVV/2021, PROGRES Q35)
- Grantová Agentura České Republiky (GA21-30795S)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- ghrelin, GHS-R1a, growth hormone secretagogue receptor, drug addiction, nicotine dependence, opioid use disorder, stimulant use disorder, relapse prevention, addiction pharmacotherapy, genetic variation
- MeSH terms
- Clinical Studies as Topic, Central Nervous System Stimulants, Animals, Disease Models, Animal, Disease Susceptibility, Humans, Nicotine, Reinforcement, Psychology, Signal Transduction, Biomarkers, Substance-Related Disorders, Genetic Predisposition to Disease, Ghrelin, Receptors, Ghrelin, Tobacco Use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. https://app.cochat.ai/papers/10.3390/ijms23020761
- The paper
- Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R. (2022). The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23020761
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.